Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness

Low-Dose Lithium for Mild Cognitive Impairment

Why Some People Thrive on Four Hours of Sleep

The Rise of the Self-Serve Blood Test

GLP-1 Semaglutide Fails to Outperform Placebo in Phase 3 EVOKE Trial of Alzheimer Disease | NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Intranasal Oxytocin for Managing Agitation in a Patient of Mixed Dementia With Multiple Pathologies, Particularly With a History of Repetitive Head Injuries - Naresh Jadav, Sümeyye Kuş, James Ellison,...

How lithium went from 7Up to treatment for mental illness — and maybe Alzheimer’s

Approaches and Considerations in Mild Cognitive Impairment Due to Alzheimer

Building an Infrastructure to Administer Amyloid-Targeting Treatments

Lilly Gets FDA Label Update for Alzheimer’s Drug To Mitigate Safety Concerns

Sage’s Search for Lifeline Ran Into Defiant Biogen CEO

Life in the Dementia Clinic: Contextualizing Treatment Options for Early Stages of Alzheimer's Disease

Kennedy Withdraws Funding Pledge to International Vaccine Agency

UK lays out strategy to become a top 3 life sciences economy by 2035

From No Hope to a Potential Cure for a Deadly Blood Cancer

An Expensive Alzheimer’s Lifestyle Plan Offers False Hope, Experts Say

Monoclonal antibody administration in an academic institution and private neurological practice: a tale of two clinics - Journal of Neurology

Lecanemab Treatment in a Specialty Memory Clinic

Real-World Experience With Long-Term Lecanemab Treatment: A Retrospective Chart Review in Early Alzheimer's Disease

USDA rolls back plans to limit salmonella levels in raw chicken, turkey

Approaches and Considerations in Mild Cognitive Impairment Due to Alzheimer

Dr Oz Ridiculed for Advising Americans to Use Less Drugs to Reduce Drug Spending: 'Tell That to a Diabetic'

Are Appropriate Use Recommendations useful in clinical practice?

Makary says FDA will remove pharma representatives from advisory panels

HEALTH AND FOOD SAFETY - Commission authorises medicine for treatment of early Alzheimer’s disease

‘The Pitt’ Captures the Real Overcrowding Crisis in Emergency Rooms

Valiltramiprosate Demonstrates Greater Promise in Milder Forms of Alzheimer Disease, Phase 3 APOLLOE4 Study Shows